Influence of micelle solubilization by tocopheryl polyethylene glycol succinate (TPGS) on solubility enhancement and percutaneous penetration of estradiol

Journal of Controlled Release

Volumn 88, Issue 3, 2003, Pages 355-368

  Sheu, Ming Thau ^a   Chen, Shin Yi ^a   Chen, Ling Chun ^a   Ho, Hsiu O ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Estradiol; Micelles; Penetration; Solubilization; TPGS

Indexed keywords

CRITICAL MICELLE CONCENTRATION; ETHANOL; POLYETHYLENE GLYCOLS; SOLUBILITY; SURFACE ACTIVE AGENTS;

PERCUTANEOUS PENETRATION;

MICELLES;

ALCOHOL; ESTRADIOL; PROPANEDIOL DERIVATIVE; TOCOPHERYL POLYETHYLENE GLYCOL SUCCINATE; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; DRUG PENETRATION; DRUG SOLUBILITY; MICELLE; PRIORITY JOURNAL; SKIN PENETRATION; SKIN PERMEABILITY; SOLUBILIZATION; STRATUM CORNEUM;

EID: 0037467195     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(02)00492-3     Document Type: Article

References (28)

1. Kydonieus A.F., Berner B. Transdermal Delivery of Drugs. 1987;69-77 CRC Press, Boca Raton, FL.
2. Blank I.H. Cutaneous barrier. J. Invest. Dermatol. 45:1965;240-256.
3. Liu C.H., O Ho H., Hsieh M.C., Sokoloski T.D., Sheu M.T. Studies on the in vitro percutaneous penetration of indomethacin from gel systems in hairless mice. J. Pharm. Pharmacol. 47:1995;365-372.
4. Walker R.B., Smith E.W. The role of percutaneous penetration enhancers. Adv. Drug Deliv. Rev. 18:1996;295-301.
5. Obata Y., Takayama K., Maitani Y., Machida Y., Nagai T. Effect of ethanol on skin permeation of nonionized and ionized diclofenac. Int. J. Pharm. 89:1993;191-198.
6. Berner B., Otte J.H., Mazzenga G.C., Steffens R.J., Ebert C.D. Ethanol:water mutually enhanced transdermal therapeutic system. I: Nitroglycerin solution properties and membrane transport. J. Pharm. Sci. 78:1989;314-318.
7. Takahashi K., Tamagawa S., Katagi T., Yoshitomi H., Kamada A., Rytting J., Nishihata T., Mizuno N. In vitro transport of sodium diclofenac across rat abdominal skin: effect of selection of oleaginous component and the addition of alcohols to the vehicle. Chem. Pharm. Bull. 39:1991;154-158.
8. Golden G.M., McKie J.E., Potts R.O. Role of stratum corneum lipid fluidity in transdermal drug flux. J. Pharm. Sci. 76:1987;25-28.
9. Aungst B.J., Rogers N.J., Shefter E. Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amines. Int. J. Pharm. 33:1986;225-234.
10. Katayama K., Takahashi O., Matsui R., Morigaki S., Aiba T., Kakemi M., Koizumi T. Effect of 1-menthol on the permeation of indomethacin, mannitol and cortisone through excised hairless mouse skin. Chem. Pharm. Bull. 40:1992;3097-3099.
11. Takayama K., Kikuchi K., Obata Y., Okabe H., Machida Y., Nagai T. Terpenes as percutaneous absorption promoters. STP Pharm. Sci. 87:1991;83-88.
12. Barry B.W., Williams A.C. Terpenes and the liquid-protein-partitioning theory of skin penetration enhancement. Pharm. Res. 8:1991;17-24.
13. Good W.R., Powers M.S., Campbell P., Schenicel L. A new transdermal delivery system for estradiol. J. Control. Release. 2:1985;89-97.
14. R.M. Gale, V. Goetz, E.S. Lee, L.T. Taskovich, S.I. Yum, Device for delivering fentanyl across the skin at a constant rate to maintain analgesia over a long period, US Patent 4,588,580 (1986).
15. Barry B.W. Action of skin penetration enhancers-lipid protein partitioning theory. Int. J. Cosmet. Sci. 10:1988;284-293.
16. Kaplun-Frischoff Y., Touitou E. Testosterone skin permeation enhancement by menthol through formation of elutectic with drug and interaction with skin lipids. J. Pharm. Sci. 86:1997;1394-1399.
17. 1 through hairless mouse skin: combined use of carboxymethyl-ethyl-β-cyclodextrin and penetration enhancers. J. Pharm. Pharmacol. 44:1992;119-121.
18. el Maghraby G.M.M., Williams A.C., Barry B.W. Skin delivery of oestradiol from deformable and traditional liposomes: mechanism studies. J. Pharm. Pharmacol. 51:1999;1123-1134.
19. Amidon G.E., Higuchi W.I., Ho N.F.H. Theoretical and experimental studies of transport of micelle-solubilized solutes. J. Pharm. Sci. 71:1982;77-84.
20. Sokol R.J., Butler-Simon N., Conner C., Hebui J.E., Sinatra F.R., Suchy F.J., Heyman M.B., Perrault J., Rothbaum R.J., Levy J., Lannaccone S.T., Shneider B.L., Koch T.K., Narkewicz M.R. Multicenter trial of d-α-tocopherol polyethylene glycol 1000 succinate for treatment of vitamin E deficiency in children with chronic cholestasis. Gastroenterology. 104:1993;1727-1735.
21. Sokol R.J., Johnson K.E., Karrer F.M., Narkewicz M.R., Smith D., Kam I. Improvement of cyclosporin absorption in children after liver transplantation by means of water-soluble vitamin E. Lancet. 338:1991;212-215.
22. Chang T., Benet L.Z., Hebert M.F. The effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers. Clin. Pharmacol. Ther. 59:1996;297-303.
23. Hebert M.F. Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery. Adv. Drug Deliv. Rev. 27:1997;201-214.
24. Yu L., Bridgers A., Polli J., Vickers A., Long S., Roy A., Winnike R., Coffin M. Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability. Pharm. Res. 16:1999;1812-1817.
25. Traber M.G., Thellman C.A., Rindler M.J., Kayden H.J. Uptake of intact TPGS a water-miscible form of vitamin E by human cells in vitro. Am. J. Clin. Nutr. 48:1988;605-611.
26. Ismailos G., Reppas C., Maacheras P. Enhancement of cyclosporine A solubility by d-alphatocopheryl-polyethylene-glycol-1000 succinate (TPGS). Eur. J. Pharm. Sci. 1:1994;269-271.
27. Bommannan D., Potts R.O., Guy R.H. Examination of the effect of ethanol on human stratum corneum in vivo using infrared spectroscopy. J. Control. Release. 16:1991;299-304.
28. Megrab N.A., Williams A.C., Barry B.W. Oestradiol permeation across human skin, Silastic and snake skin membranes: the effect of ethanol/water co-solvent systems. Int. J. Pharm. 116:1995;101-112.